Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin Apotheke
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in: Wiener klinische Wochenschrift 11-12/2013

01.06.2013 | case report

Infective endocarditis caused by Cellulomonas spp. in an intravenous drug user: case report

verfasst von: Mateja Logar, MD, PhD, Tatjana Lejko-Zupanc, MD, PhD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2013

Einloggen, um Zugang zu erhalten

Summary

Cellulomonas spp. are often believed to be of low virulence. There are only a few reports of human infections. We report the first case of endocarditis caused by Cellulomonas in an intravenous drug abuser. The diagnosis of infective endocarditis (IE) in this case was definite using the Duke criteria. The course of the disease was complicated with a heart failure and possible mycotic aneurysm in the left leg. After the end of antimicrobial therapy aortic valve replacement was done because of severe heart failure.
Vorheriger Artikel Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases
Nächster Artikel Foreign body pulmonary embolism
Literatur
1.
Miró JM, del Río A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin North Am. 2002;16:273–95.PubMedCrossRef
2.
Carozza A, De Santo LS, Romano G, et al. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006;15:125–31.PubMed
3.
Lai PC, Chen YS, Lee SS. Infective endocarditis and osteomyelitis caused by Cellulomonas: a case report and review of the literature. Diagn Microbiol Infect Dis. 2009;65:184–7.PubMedCrossRef
4.
Ohtaki H, Ohkusu K, Sawamura H, et al. First report of acute cholecystitis with sepsis caused by Cellulomonas denverensis. J Clin Microbiol. 2009;470:3391–3.CrossRef
5.
Sharma S, Saffra NA, Chinyadza T, et al. Endocapsular cellulomonas as a cause of persistent postoperative endophthalmitis. Ophthalmic Surg Lasers Imaging. 2008;39:328–30.PubMedCrossRef
6.
Dong-Shan A, Wan-Taek I, Hee-Chan Y, et al. Cellulomans terrae sp. nov., a cellulolytic and xylanolytic bacterium isolated from soil. Int J Syst Evol Microbiol. 2005;55:1705–9.CrossRef
7.
Min-Ho Y, Leonid NT, Wan-Taek I, et al. Cellulomans chitinilytica sp. nov., a chitinolytic bacterium isolated from soil. Int J Syst Evol Microbiol. 2008;58:1878–84.CrossRef
8.
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.PubMedCrossRef
9.
Fowler VG Jr, Scheld MW, Bayer AS. Endocarditis and intravascular infections. In: Mandel GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier; 2010. pp. 1067–113.
10.
Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1–142.PubMedCrossRef
11.
Olaison L, Pettersson G. Current best practices and guidelines. Indications for surgical intervention in infective endocarditis. Cardiol Clin. 2003;21:235–51.PubMedCrossRef
12.
Kiefer T, Park L, Tribouilloy C, Cortes C, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239–47.PubMedCrossRef
13.
Nardi P, Pellegrino A, Scafuri A, et al. Permanent pacemaker implantation after isolated aortic valve replacement: incidence, risk factors and surgical technical aspects. J Cardiovasc Med. 2010;11:14–9.CrossRef
Metadaten
Titel
Infective endocarditis caused by Cellulomonas spp. in an intravenous drug user: case report
verfasst von
Mateja Logar, MD, PhD
Tatjana Lejko-Zupanc, MD, PhD
Publikationsdatum
01.06.2013
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 11-12/2013
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0367-6

Weitere Artikel der Ausgabe 11-12/2013

Wiener klinische Wochenschrift 11-12/2013 Zur Ausgabe

konsensus bericht

Stellungnahme der Österreichischen Röntgengesellschaft und der Österreichischen Gesellschaft für Pneumologie


case report

Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases

case report

Foreign body pulmonary embolism

original article

Incidence and long-term outcome of sepsis on general wards and in an ICU at the General Hospital of Vienna: an observational cohort study

Erratum

Erratum to: Female and male victims of violence in an urban emergency room—prevalence, sociodemographic characteristics, alcohol intake, and injury patterns

original article

Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients